Max Pohjanpelto

Max Pohjanpelto

Auto-generated profile, based on publicly available information

Max Pohjanpelto

Genetics Section, Molecular and Clinical Sciences, St George’s, University of London

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2022 in European Journal of Paediatric Neurology
Verified
Journal Article
Open access
EIErika Ignatius
Erika Ignatius
RPRiina Puosi
Riina Puosi
MPMaarit Palomäki
Maarit Palomäki
NFNoora Forsbom
Noora Forsbom
MPMax Pohjanpelto
Max Pohjanpelto
PIPirjo Isohanni
Pirjo Isohanni
Deleterious variants in the transcription factor early B-cell factor 3 (EBF3) are known to cause a neurodevelopmental disorder (EBF3-NDD). We report eleven individuals with EBF3 variants, including an individual with a duplication/triplication mosaicism of a region encompassing EBF3 and a phenotype consistent with EBF3-NDD, which may reflect the importance of EBF3 gene-dosage for neurodevelopment. The phenotype of individuals in this cohort was quite mild compared to the core phenotype of previously described individuals. Although ataxia tended to wane with age, we show that cognitive difficulties may increase, and we recommend that individuals with EBF3-NDD have systematic neuropsychological follow-up.

1 August 2020 in Neurology Genetics
Verified
Journal Article
Open access
PDF file
EIErika Ignatius
Erika Ignatius
PIPirjo Isohanni
Pirjo Isohanni
MPMax Pohjanpelto
Max Pohjanpelto
PLPäivi Lahermo
Päivi Lahermo
SOSimo Ojanen
Simo Ojanen
CCChristopher J. Carroll
Christopher J. Carroll
Objective To characterize the genetic background of molecularly undefined childhood-onset ataxias in Finland. Methods This study examined a cohort of patients from 50 families with onset of an ataxia syndrome before the age of 5 years collected from a single tertiary center, drawing on the advantages offered by next generation sequencing. A genome-wide genotyping array (Illumina Infinium Global Screening Array MD-24 v.2.0) was used to search for copy number variation undetectable by exome sequencing. Results Exome sequencing led to a molecular diagnosis for 20 probands (40%). In the 23 patients examined with a genome-wide genotyping array, 2 additional diagnoses were made. A considerable proportion of probands with a molecular diagnosis had de novo pathogenic variants (45%). In addition, the study identified a de novo variant in a gene not previously linked to ataxia: MED23. Patients in the cohort had medically actionable findings. Conclusions There is a high heterogeneity of causative mutations in this cohort despite the defined age at onset, phenotypical overlap between patients, the founder effect, and genetic isolation in the Finnish population. The findings reflect the heterogeneous genetic background of ataxia seen worldwide and the substantial contribution of de novo variants underlying childhood ataxia.

15 June 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
THTaru Hilander
Taru Hilander
GMgeoffray monteuuis
geoffray monteuuis
RARyan Awadhpersad
Ryan Awadhpersad
KBKrystyna L. Broda
Krystyna L. Broda
MPMax Pohjanpelto
Max Pohjanpelto
CCChristopher J. Carroll
Christopher J. Carroll
Summary: Mitochondrial ribosomes (mitoribosomes) have undergone substantial structural remodelling throughout evolution. Compared to their prokaryotic counterparts, mitoribosomes show a substantial loss of ribosomal RNA, whilst acquiring unique protein subunits located on the periphery of the ribosomal subunit structures. We set out to investigate the functional properties of all 14 unique (mitochondrial-specific or supernumerary) human mitoribosomal proteins in the small subunit. Using genome editing with CRISPR-Cas9, we made knockouts for each subunit in HEK293 cells to study the effect on mitoribosome assembly and function in protein synthesis. Unexpectedly, we show that each supernumerary knockout leads to a unique mitoribosome assembly defect with variable impact on mitochondrial protein synthesis. Our data demonstrates that all supernumerary subunits are essential structural components except mS37. Surprisingly, we found the stability of mS37 was reduced in all our supernumerary knockouts of the small and large ribosomal subunits as well as patient-derived lines with mitoribosome assembly defects. We identified that a redox regulated CX 9 C motif in mS37 was essential for protein stability, suggesting a potential mechanism to regulate mitochondrial protein synthesis. Together, our findings support a modular assembly of the human mitochondrial small ribosomal subunit mediated by essential supernumerary subunits and identify a redox regulatory role involving mS37 in mitochondrial protein synthesis in health and disease.